LoCorr Funds Declares 2016 Year-End Distributions

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
LoCorr Funds Declares 2016 Year-End Distributions

MINNEAPOLIS, Dec. 12, 2016 (GLOBE NEWSWIRE) -- LoCorr Funds announced the declaration of their annual capital gains and dividend distributions for 2016 for the LoCorr Managed Futures Strategy Fund, LoCorr Long/Short Commodities Strategy Fund, LoCorr Market Trend Fund, LoCorr Long/Short Equity Fund, LoCorr Spectrum Income Fund and LoCorr Multi-Strategy Fund. The Funds paid the following dividends:

Fund Long-Term   Gain  Short-Term  Gain     Income     Total   Distribution  
LoCorr Managed Futures Strategy Fund – Class A (LFMAX)   $ 0.1418 $ 0.0337  - $ 0.1755
LoCorr Managed Futures Strategy Fund – Class C (LFMCX)     $ 0.1418 $ 0.0337  - $ 0.1755
LoCorr Managed Futures Strategy Fund – Class I (LFMIX) $ 0.1418   $ 0.0337 $ 0.0005   $ 0.1760
LoCorr L/S Commodities Strategy Fund – Class A (LCSAX)  -  -   $ 0.2674 $ 0.2674
LoCorr L/S Commodities Strategy Fund – Class C (LCSCX)  -  - $ 0.2124 $ 0.2124
LoCorr L/S Commodities Strategy Fund – Class I (LCSIX)  -  - $ 0.2962 $ 0.2962
LoCorr Market Trend Fund – Class A (LOTAX)  -  - $ 0.1870 $ 0.1870
LoCorr Market Trend Fund – Class C (LOTCX)  -  - $ 0.1464 $ 0.1464
LoCorr Market Trend Fund – Class I (LOTIX)  -  - $ 0.2016 $ 0.2016
LoCorr Long/Short Equity – Class A (LEQAX)  -  -  -  -
LoCorr Long/Short Equity – Class C (LEQCX)  -  -  -  -
LoCorr Long/Short Equity – Class I (LEQIX)  -  -  -  -
LoCorr Spectrum Income Fund – Class A (LSPAX)  -  -  -  -
LoCorr Spectrum Income Fund – Class C (LSPCX)  -  -  -  -
LoCorr Spectrum Income Fund – Class I (LSPIX)  -  -  -  -
LoCorr Multi-Strategy Fund – Class A (LMUAX)  -  -  -  -
LoCorr Multi-Strategy Fund – Class C (LMUCX)  -  -  -  -
LoCorr Multi-Strategy Fund – Class I (LMUIX)  -  -  -  -
         

As a result of the distribution, the LoCorr Managed Futures Strategy Fund, LoCorr Long/Short Commodities Strategy Fund, and LoCorr Market Trend Fund NAV’s dropped accordingly on ex-date (12/9/16).

About LoCorr Funds LoCorr Funds today is well-known for educating both advisors and investors about the potential advantages of including alternative investments in portfolios. The LoCorr suite of alternative investment vehicles includes the LoCorr Managed Futures Strategy Fund, LoCorr Long/Short Commodities Strategy Fund, LoCorr Long/Short Equity Fund, LoCorr Spectrum Income Fund, LoCorr Market Trend Fund, and LoCorr Multi-Strategy Fund.

Since its founding, LoCorr Funds has promoted the use of low-correlating investment strategies for the potential of enhancing returns and reducing risk in portfolios. Through its strong distribution network, we believe the firm remains well positioned for continued growth as investors demand alternatives to traditional investments to help achieve portfolio diversification. LoCorr Funds is headquartered in Excelsior, MN.  For more information, please visit www.LoCorrFunds.com , www.LoCorrFundManagement.com , or call 1.888.628.2887.

The Fund’s investment objectives, risks, charges and expenses must be considered carefully before investing. The prospectus contains this and other important information about the investment company, and it may be obtained by calling 1.855.LCFUNDS, or visiting www.LoCorrFunds.com . Read it carefully before investing.

Mutual fund investing involves risk. Principal loss is possible. Non-diversified investments may concentrate assets in fewer individual holdings than diversified investments. Therefore, the investments are more exposed to individual stock volatility than diversified funds. The Funds invest in foreign investments and foreign currencies which involve greater volatility and political, economic and currency risks and differences in accounting methods. These risks are greater for emerging markets. The Funds may make short sales of securities, which involves the risk that losses may exceed the original amount invested. Investing in commodities may subject the Funds to greater risks and volatility as commodity prices may be influenced by a variety of factors including unfavorable weather, environmental factors, and changes in government regulations. The Funds may invest in derivative securities, which derive their performance from the performance of an underlying asset, index, interest rate or currency exchange rate. Derivatives can be volatile and involve various types and degrees of risks, and, depending upon the characteristics of a particular derivative, suddenly can become illiquid. Investments in debt securities typically decrease in value when interest rates rise. This risk is usually greater for longer-term debt securities. Investments in Asset Backed, Mortgage Backed, and Collateralized Mortgage Backed Securities include additional risks that investors should be aware of such as credit risk, prepayment risk, possible illiquidity and default, as well as increased susceptibility to adverse economic developments.  Investments in small- and medium-capitalization companies involve additional risks such as limited liquidity and greater volatility. Investments in lower-rated and non-rated securities present a greater risk of loss to principal and interest than higher-rated securities. ETF investments are subject to investment advisory and other expenses, which will be indirectly paid by the Funds. As a result, the cost of investing in the Funds will be higher than the cost of investing directly in ETFs and may be higher than other mutual funds that invest directly in stocks and bonds. ETFs are subject to specific risks, depending on the nature of the ETF. A Fund’s real estate portfolio may be significantly impacted by the performance of the real estate market generally, and the Fund may be exposed to greater risk and experience higher volatility than would a more economically diversified portfolio. Property values may fall due to increasing vacancies or declining rents resulting from economic, legal, cultural, or technological developments. Investments in Limited Partnerships (including master limited partnerships) involve risks different from those of investing in common stock including risks related to limited control and limited rights to vote on matters affecting the Limited Partnership, risks related to potential conflicts of interest between the Limited Partnership and the Limited Partnership’s general partner, cash flow risks, tax risk, dilution risks and risks related to the general partner’s limited call right. Underlying Funds are subject to management and other expenses, which will be indirectly paid by the Fund.

Opinions expressed are subject to change at any time, are not guaranteed and should not be considered investment advice. Correlation measures how much the returns of two investments move together over time.

Any tax or legal information provided is merely a summary of our understanding and interpretation of some of the current income tax regulations and it is not exhaustive. Investors must consult their tax advisor or legal counsel for advice and information concerning their particular situation. Neither the Funds nor any of its representatives may give legal or tax advice.

Diversification does not assure a profit nor protect against loss in a declining market.

The LoCorr Funds are distributed by Quasar Distributors, LLC.

© 2016 LoCorr Funds

Media Contact: Kristen Anderson, Marketing & Communications, 952.767.6908

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 250

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 88

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 241

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 47

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
IS: Thai Approval Opens New Sarcoma Treatment Path"> Continue Reading